{"id":20173,"date":"2020-10-27T18:35:06","date_gmt":"2020-10-27T18:35:06","guid":{"rendered":"https:\/\/medipurpose.com\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/"},"modified":"2020-11-09T20:17:54","modified_gmt":"2020-11-09T20:17:54","slug":"surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos","status":"publish","type":"post","link":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/","title":{"rendered":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos"},"content":{"rendered":"<p>ATLANTA y NORCROSS, Ga., 7 de junio &#8212; SurgiLance Inc. anunci\u00f3 hoy que ha ganado una apelaci\u00f3n de una sentencia de infracci\u00f3n de patente de dispositivo m\u00e9dico.<\/p>\n<p>La decisi\u00f3n del 11\u00b0 Tribunal de Apelaciones del Circuito de los Estados Unidos en Atlanta pone fin a la disputa de cuatro a\u00f1os iniciada por su competidor Owen Mumford, Inc. (OM) contra SurgiLance Inc. y su matriz en Singapur, SurgiLance Pte Ltd. .<\/p>\n<p>Owen Mumford, Inc. (OM) hab\u00eda afirmado que el dise\u00f1o de la lanceta de seguridad de un solo movimiento estaba violando una patente en papel en poder de Owen Mumford.<\/p>\n<p>El 22 de junio de 2004, el Tribunal de Distrito de los Estados Unidos para el Distrito Norte de Georgia (Atlanta) dictamin\u00f3 que la lanceta de seguridad de un solo movimiento infringi\u00f3 la patente de OM, pero otorg\u00f3 a SurgiLance el derecho a una apelaci\u00f3n inmediata.<\/p>\n<p>La decisi\u00f3n de hoy revoca la sentencia de infracci\u00f3n del tribunal de distrito y le indica que dicte sentencia de NO infracci\u00f3n.<\/p>\n<p>El fundador y CEO de SurgiLance, Patrick Yi, est\u00e1 muy satisfecho con la decisi\u00f3n del tribunal de apelaciones.<\/p>\n<p>\u00abEsto reivindica la posici\u00f3n que hemos mantenido todo el tiempo: hemos inventado nuestro propio producto\u00bb, dijo Yi. \u00abInvestigamos el mercado de manera responsable y exhaustiva, lo que result\u00f3 en el desarrollo de nuestro propio dise\u00f1o \u00fanico\u00bb.<\/p>\n<p>El vicepresidente de ventas y marketing de SurgiLance, Alan Wells, est\u00e1 igualmente satisfecho con el fallo.<\/p>\n<p>\u00abLamentamos el tiempo y los gastos que implicaron defender nuestra posici\u00f3n\u00bb, dijo Wells. \u00abSin embargo, estamos muy contentos de que ahora podamos centrar todos nuestros recursos en nuestras leg\u00edtimas ventajas competitivas en el mercado y seguir creciendo el negocio como lo hemos hecho en los \u00faltimos cuatro a\u00f1os, a pesar de esta distracci\u00f3n legal\u00bb.<\/p>\n<p>Ed. Nota: Esta versi\u00f3n fue publicada antes de que MediPurpose cambiara su nombre.<br \/>\n SurgiLance en 2006.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA y NORCROSS, Ga., 7 de junio &#8212; SurgiLance Inc. anunci\u00f3 hoy que ha ganado una apelaci\u00f3n de una sentencia de infracci\u00f3n de patente de dispositivo m\u00e9dico. La decisi\u00f3n del 11\u00b0 Tribunal de Apelaciones del Circuito de los Estados Unidos en Atlanta pone fin a&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[232,219],"tags":[],"class_list":["post-20173","post","type-post","status-publish","format-standard","hentry","category-news-es","category-sin-categorizar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose\" \/>\n<meta property=\"og:description\" content=\"ATLANTA y NORCROSS, Ga., 7 de junio &#8212; SurgiLance Inc. anunci\u00f3 hoy que ha ganado una apelaci\u00f3n de una sentencia de infracci\u00f3n de patente de dispositivo m\u00e9dico. La decisi\u00f3n del 11\u00b0 Tribunal de Apelaciones del Circuito de los Estados Unidos en Atlanta pone fin a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/\" \/>\n<meta property=\"og:site_name\" content=\"MediPurpose\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-27T18:35:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-09T20:17:54+00:00\" \/>\n<meta name=\"author\" content=\"Patrick Yi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrick Yi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/\"},\"author\":{\"name\":\"Patrick Yi\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/#\\\/schema\\\/person\\\/b0588d7c06517529430fd6f3a3bca82a\"},\"headline\":\"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos\",\"datePublished\":\"2020-10-27T18:35:06+00:00\",\"dateModified\":\"2020-11-09T20:17:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/\"},\"wordCount\":333,\"commentCount\":0,\"articleSection\":[\"Noticias\",\"Sin categorizar\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/\",\"url\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/\",\"name\":\"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/#website\"},\"datePublished\":\"2020-10-27T18:35:06+00:00\",\"dateModified\":\"2020-11-09T20:17:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/#\\\/schema\\\/person\\\/b0588d7c06517529430fd6f3a3bca82a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/\",\"name\":\"MediPurpose\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/#\\\/schema\\\/person\\\/b0588d7c06517529430fd6f3a3bca82a\",\"name\":\"Patrick Yi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g\",\"caption\":\"Patrick Yi\"},\"description\":\"Patrick Yi founded MediPurpose in 1999. He brings to MediPurpose an extensive and varied background of management, marketing and business development experience in a variety of industry segments, including retail, electronic payment systems, information technology and real estate.\",\"url\":\"https:\\\/\\\/medipurpose.com\\\/es\\\/author\\\/patrick-yi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/","og_locale":"es_ES","og_type":"article","og_title":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose","og_description":"ATLANTA y NORCROSS, Ga., 7 de junio &#8212; SurgiLance Inc. anunci\u00f3 hoy que ha ganado una apelaci\u00f3n de una sentencia de infracci\u00f3n de patente de dispositivo m\u00e9dico. La decisi\u00f3n del 11\u00b0 Tribunal de Apelaciones del Circuito de los Estados Unidos en Atlanta pone fin a...","og_url":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/","og_site_name":"MediPurpose","article_published_time":"2020-10-27T18:35:06+00:00","article_modified_time":"2020-11-09T20:17:54+00:00","author":"Patrick Yi","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Patrick Yi","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/#article","isPartOf":{"@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/"},"author":{"name":"Patrick Yi","@id":"https:\/\/medipurpose.com\/es\/#\/schema\/person\/b0588d7c06517529430fd6f3a3bca82a"},"headline":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos","datePublished":"2020-10-27T18:35:06+00:00","dateModified":"2020-11-09T20:17:54+00:00","mainEntityOfPage":{"@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/"},"wordCount":333,"commentCount":0,"articleSection":["Noticias","Sin categorizar"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/","url":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/","name":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos - MediPurpose","isPartOf":{"@id":"https:\/\/medipurpose.com\/es\/#website"},"datePublished":"2020-10-27T18:35:06+00:00","dateModified":"2020-11-09T20:17:54+00:00","author":{"@id":"https:\/\/medipurpose.com\/es\/#\/schema\/person\/b0588d7c06517529430fd6f3a3bca82a"},"breadcrumb":{"@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medipurpose.com\/es\/surgilance-prevalece-en-caso-de-infraccion-de-patentes-de-dispositivos-medicos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medipurpose.com\/es\/"},{"@type":"ListItem","position":2,"name":"SurgiLance\u2122 prevalece en caso de infracci\u00f3n de patentes de dispositivos m\u00e9dicos"}]},{"@type":"WebSite","@id":"https:\/\/medipurpose.com\/es\/#website","url":"https:\/\/medipurpose.com\/es\/","name":"MediPurpose","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medipurpose.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/medipurpose.com\/es\/#\/schema\/person\/b0588d7c06517529430fd6f3a3bca82a","name":"Patrick Yi","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b34407a550d0ca27af23583e9f0606a418df1ba169f49473edd346f6ec35ebda?s=96&d=mm&r=g","caption":"Patrick Yi"},"description":"Patrick Yi founded MediPurpose in 1999. He brings to MediPurpose an extensive and varied background of management, marketing and business development experience in a variety of industry segments, including retail, electronic payment systems, information technology and real estate.","url":"https:\/\/medipurpose.com\/es\/author\/patrick-yi\/"}]}},"_links":{"self":[{"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/posts\/20173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/comments?post=20173"}],"version-history":[{"count":1,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/posts\/20173\/revisions"}],"predecessor-version":[{"id":20336,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/posts\/20173\/revisions\/20336"}],"wp:attachment":[{"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/media?parent=20173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/categories?post=20173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medipurpose.com\/es\/wp-json\/wp\/v2\/tags?post=20173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}